Pharma Stands Up To Trump Pressure With COVID-19 Vaccines Science Pledge

New US Poll Shows Public Distrust

CEOs from the most advanced vaccines developers pledge to maintain standards – for the sake of safety, efficacy and public trust in vaccines.

single Sars-cov-2 coronavirus vaccine
The timing of a potential approval has become a political issue ahead of the election - and is undermining US public faith in COVID-19 vaccines.

Chief executives of nine US and European biopharma companies leading COVID-19 vaccines development have come together to pledge that safety and efficacy will not be compromised in order to gain rapid approval for their products.

The companies include Pfizer Inc./BioNTech SE, Moderna, Inc. and AstraZeneca PLC, which say they could still...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip